Online Program Home
  My Program
CC = Baltimore Convention Center,    H = Hilton Baltimore
* = applied session       ! = JSM meeting theme

Activity Details

493 * ! Wed, 8/2/2017, 10:30 AM - 12:20 PM CC-329
Bayesian Model-Based and Rule-Based Dose Escalation Designs in Oncology — Topic Contributed Papers
Section on Bayesian Statistical Science , Biopharmaceutical Section
Organizer(s): Charles Liu, Cytel Inc.
Chair(s): Erik Pulkstenis, Medimmune
10:35 AM A Case Study Exploration of MTPI and Proposed Methods to Expand to Combination Drug Development Matthew Gribbin, MedImmune ; Nairouz Elgeioushi, MedImmune
10:55 AM Alternative Dose Escalation Rules for Dual Agent Designs Charles Liu, Cytel Inc. ; Yannis Jemiai, Cytel Inc. ; Sam Hsiao, Cytel, Inc ; Hrishikesh Kulkarni, Cytel Inc.
11:15 AM Combination Dose Finding in Phase I Oncology Trials: a Co-Data Approach Niladri Roy Chowdhury, Novartis Oncology Pharmaceuticals ; Satrajit Roychoudhury, Pfizer Inc
11:35 AM Model-based Design for the Early Development of Cancer Immunotherapy Combinations Nolan Wages, University of Virgina
11:55 AM Discussant: Guan Xing, Gilead
12:15 PM Floor Discussion
Copyright © American Statistical Association